B7h Activators

B7h Activators are a select group of chemical compounds that enhance the functional activity of B7h through various signaling pathways, each influencing different aspects of the immune response. Isoproterenol, Forskolin, and Prostaglandin E2 (PGE2) all elevate intracellular cAMP levels, which are known to have a profound effect on lymphocyte functions and could enhance the co-stimulatory capacity of B7h by activating protein kinase A (PKA) and other downstream effectors. Phorbol 12-myristate 13-acetate (PMA) and Ionomycin work synergistically to activate protein kinase C (PKC) and increase intracellular calcium levels, respectively, both of which are crucial for T-cell receptor signaling and could potentially enhance B7h's role in T-cell activation. A23187 also raises intracellular calcium, further potentiating the activation of T-cells in conjunction with B7h.

Moreover, compounds like Retinoic acid and 1,25-Dihydroxyvitamin D3 activate nuclear receptors leading to altered gene expression, which may include the upregulation of B7h, thereby enhancing its immune modulation role. Pathogen-associated molecular patterns (PAMPs) such as LPS, CpG Oligodeoxynucleotide, and Imiquimod, known agonists of TLR4, TLR9, and TLR7 respectively, induce B7h expression on antigen-presenting cells, amplifying its co-stimulatory signal for T-cell activation. Anisomycin, by activating stress-activated protein kinases, represents another mechanism by which the expression of B7h can be enhanced, promoting its role in T-cell co-stimulation. Collectively, these B7h Activators work through distinct but converging pathways that ultimately potentiate the immune regulatory functions of B7h.